Case Description: 56-year-old transgender woman with new spinal cord injury (SCI) on gender affirming hormonal therapy (GAHT) with estrogen and spironolactone.
Findings: After her injury, estrogen and spironolactone were discontinued, for blood clots and hypotension, respectively. Alternative options were explored.
Clinical Relevance: Little is known about GAHT in SCI for transgender women. Shared decision making should be used to navigate risks, benefits, and alternative options.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10790268.2024.2396644 | DOI Listing |
Publication Analysis
Top Keywords
gender affirming
8
transgender women
8
spinal cord
8
cord injury
8
alternative options
8
nuances gender
4
affirming therapy
4
therapy transgender
4
women spinal
4
injury case
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!